PRESS-RELEASE ·Filed Sep 16, 2026
Press release: leadership
Actionable Insight • Neutral
Leadership change is routine and unlikely to move the stock. Monitor next quarterly earnings for any commercial execution impact under new leadership.
Latest settled — T+5d ⚠ clustered
MYGN ▲ +3.89% at T+5d
NEUTRAL call ✓ call won +3.89% · α vs SPY +1.32% · entry $3.86 → $4.01
Latest observation: T+11 +17.58% FF3 residual α
T+1d
+7.25%
call +7.25% · α +6.12%
$4.14
settled 15d ago
T+5d
+3.89%
call +3.89% · α +1.32%
$4.01
settled 9d ago
T+20d
—
call — · α —
—
in 12d
T+60d
—
call — · α —
—
in 2mo
Price Chart
Loading chart...
Executive Summary
Myriad Genetics announced the promotion of Vishal Sikri to EVP-Commercial, replacing departing CCO Brian Donnelly. The company reaffirmed its full-year 2026 financial guidance. This is a routine leadership change with no material financial impact.
Key Facts
- Vishal Sikri promoted to EVP-Commercial, effective September 16, 2026.
- Brian Donnelly, Chief Commercial Officer since May 2025, departing September 21, 2026.
- Full-year 2026 financial guidance reaffirmed.
Financial Impact
No financial figures provided; guidance reaffirmed.
Risk Factors
- Departure of CCO Brian Donnelly after ~16 months could signal commercial challenges.
- No new financial targets or updates provided.
Market Snapshot
Exchange
Nasdaq
Sector
In Vitro & In Vivo Diagnostic Substances
Analyst Consensus
13% bullish (15 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3363090 |
8 reports for MYGN
75% Hit rate best @ T+20▲ +7.76%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 16, 2026 16d ago | 8-K | $3.86 $4.01 | ▲ +3.89% | ▲ +1.32% | $4.54 (+17.62%) |
Sep 16, 2026 16d ago | Press Release | $3.86 $4.01 | ▲ +3.89% | ▲ +1.32% | $4.54 (+17.62%) |
Aug 4, 2026 8w ago | Press Release | $3.17 $3.22 | ▼ −1.58% | ▼ −1.68% | $4.54 (−43.22%) |
Jul 30, 2026 9w ago | Press Release | $2.86 $3.26 | ▼ −13.99% | ▼ −10.47% | $4.54 (−58.74%) |
May 27, 2026 18w ago | Press Release | $3.93 $4.31 | ▲ +9.67% | ▲ +8.46% | $4.54 (+15.52%) |
Mar 17, 2026 28w ago | Press Release | $4.64 $4.68 | ▲ +0.86% | ▲ +1.58% | $4.54 (−2.16%) |
Feb 28, 2026 30w ago | Institutional Cluster | $5.01 $4.81 | ▼ −3.99% | ▼ −2.78% | $4.54 (−9.38%) |
Feb 24, 2026 31w ago | S-3 | $4.78 $5.28 | ▲ +10.46% | ▲ +11.56% | $4.54 (−5.02%) |
Showing 8 of 8
US Market Status
Market Closed — Opens Mon (38h 37m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access